Price Alert

Novo Nordisk A/S (NONOF)

OTC: NONOF · Real-Time Price · USD

52.37

2.11 (4.20%)

At close: Aug 15, 2025, 3:44 PM

51.00

-2.61%

Pre-market: Aug 15, 2025, 11:51 AM EDT

Novo Nordisk A/S Income Statement

Financials in DKK. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	303.14B	290.4B	270.58B	258B	244.24B	232.26B	214.49B	201.32B	188.29B	176.95B	167.19B	157.25B	149.03B	140.8B	134.6B	129.91B	126.88B
Cost of Revenue	47.5B	44.52B	41.51B	39.92B	37.5B	35.77B	34.01B	31.5B	29.71B	28.45B	26.43B	25.29B	24.76B	23.66B	23.04B	22.13B	21.36B
Gross Profit	255.65B	245.88B	229.07B	218.09B	206.74B	196.5B	180.48B	169.82B	158.58B	148.51B	140.77B	131.97B	124.26B	117.14B	111.57B	107.78B	105.52B
Operating Income	134.88B	127.93B	117.96B	111.05B	109.41B	102.57B	84.09B	77.36B	71.86B	66B	71.36B	66.42B	62.81B	58.64B	56.19B	53.75B	52.81B
Interest Income	5.77B	4.49B	4.49B	6.42B	6.11B	4.82B	4.82B	3.07B	4.08B	3.44B	3.44B	2.66B	1.14B	2.68B	2.68B	2.05B	2.01B
Pretax Income	132.31B	127.19B	119.25B	112.93B	111.86B	104.67B	93.37B	83.34B	75.88B	69.06B	65.86B	62.94B	61.06B	59.08B	57.97B	55.55B	54.05B
Net Income	104.61B	100.99B	94.72B	89.9B	89.28B	83.68B	75.31B	67.24B	61.13B	55.52B	52.83B	50.54B	49.34B	47.76B	46.18B	44.36B	42.86B
Selling & General & Admin	69.08B	67.38B	65.72B	63.2B	62.53B	61.6B	58.06B	56.6B	53.01B	50.68B	48.41B	45.95B	43.02B	41.06B	39.2B	38.24B	37.56B
Research & Development	49.76B	48.06B	44.72B	43.36B	34.32B	32.44B	30.07B	27.57B	25.57B	24.05B	21.59B	20.21B	19.03B	17.77B	16.62B	16.28B	15.63B
Other Expenses	1.93B	2.51B	666M	467M	482M	-119M	-549M	-511M	-675M	-1.03B	-597M	-618M	-603M	-332M	-442M	-488M	-474M
Operating Expenses	120.77B	117.95B	111.11B	107.03B	97.33B	93.92B	87.58B	83.66B	77.91B	73.7B	69.41B	65.54B	61.45B	58.5B	55.38B	54.03B	52.71B
Interest Expense	7.57B	4.46B	4.46B	5.8B	4.52B	3.57B	3.57B	5.13B	8.1B	8.41B	8.41B	5.62B	2.37B	1.72B	1.78B	1.13B	1.65B
Selling & Marketing Expenses	63.74B	62.1B	60.57B	58.18B	57.59B	56.74B	53.32B	51.95B	48.45B	46.22B	44.11B	41.77B	38.94B	37.01B	35.14B	34.2B	33.59B
Cost & Expenses	168.16B	161.8B	151.95B	146.38B	134.26B	129.69B	121.59B	115.16B	107.62B	102.14B	95.84B	90.83B	86.22B	82.16B	78.42B	76.16B	74.07B
Income Tax Expense	27.69B	26.2B	24.53B	23.04B	22.58B	20.99B	18.06B	16.1B	14.75B	13.54B	13.03B	12.4B	11.72B	11.32B	11.79B	11.19B	11.18B
Shares Outstanding (Basic)	4.44B	4.45B	4.45B	4.46B	4.46B	4.46B	4.5B	4.49B	4.5B	4.51B	4.52B	4.54B	4.55B	4.58B	4.59B	4.61B	4.63B
Shares Outstanding (Diluted)	4.45B	4.46B	4.46B	4.47B	4.47B	4.48B	4.49B	4.5B	4.51B	4.52B	4.54B	4.55B	4.57B	4.58B	4.6B	4.61B	4.63B
EPS (Basic)	23.51	22.67	21.25	20.14	19.97	23.08	24.17	22.32	20.92	15.22	13.96	16.08	18.41	20.77	20.02	19.15	18.43
EPS (Diluted)	23.47	22.62	21.20	20.08	19.91	23.01	24.09	22.27	20.88	15.21	13.97	16.06	18.39	20.73	19.98	19.13	18.40
EBITDA	159.28B	148.56B	139.03B	131.12B	122.09B	114.34B	102.85B	97.21B	92.18B	85.61B	82.46B	76.05B	70.36B	67.47B	65.41B	63.12B	62.21B
EBIT	139.26B	128.89B	119.46B	111.17B	108.81B	101.97B	93.54B	86.81B	80.67B	74.81B	69.45B	64.51B	60.9B	56.74B	55.31B	52.87B	51.92B
Depreciation & Amortization	20.02B	19.11B	16.9B	17.28B	10.61B	9.41B	8.46B	7.97B	7.43B	7.36B	7.41B	6.72B	6.3B	6.03B	5.32B	6.1B	6.04B